EUVIMEDObjevte EUVIMED
KorrekturOpen access · CC BY 4.0

Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”

Advanced Science · 2026-06 · 13 (33)

DOI: 10.1002/advs.75571 ↗

At a glance

Korrektur in Advanced Science, published online on 2026-05-07. The full text is freely available (open access, CC BY 4.0).

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

(2026). Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science, 13(33). https://doi.org/10.1002/advs.75571

Vancouver

Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science. 2026;13(33). doi:10.1002/advs.75571

BibTeX
@article{euvimed2026,
  title = {Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {33},
  doi = {10.1002/advs.75571}
}
Start for free →